Thyroid Dysfunction Does Not Affect the Bone Mineral Density in Postmenopausal Women

Associations of vitamin D status with bone mineral density, bone turnover, bone loss and fracture risk in healthy postmenopausal women. The OFELY

The aim of this study was to determine the prevalence and factors associated with osteopenia and osteoporosis in women who have undergone bone mineral density test in a

OBJECTIVE: To evaluate how bone mineral density in the calcaneus measured by a dual energy X-ray laser (DXL) correlates with bone mineral density in the spine and hip in Turkish

ABSTRACT - The aim of this cross sectional study was to evaluate bone mineral density (BMD) and serum lev- els of 25-hydroxy vitamin D (25OHD) in a group of patients

Aim - To study a possible relationship between chronic gastritis, parietal cell density of the oxyntic mucosa and bone mineral density in postmenopausal women, as chronic

Short-term increases in bone turnover markers predict parathyroid hormone-induced spinal bone mineral density gains in postmenopausal women with glucocorticoid- induced

Effects of zoledronate versus placebo on spine bone mineral density and microarchitecture assessed by the trabecular bone score in postmenopausal women with osteoporosis: a

concluded that The prevalence of abnormal bone mineral density (BMD) was higher in postmenopausal breast cancer survivors (BCS) than in postmenopausal women without breast cancer”..